康缘药业(600557) - 2020 Q3 - 季度财报

Financial Position - Total current liabilities amounted to 1,794,901,753.79 RMB[59] - Total non-current liabilities were 75,319,917.22 RMB[59] - Total liabilities reached 1,870,221,671.01 RMB[59] - Total owner's equity (or shareholders' equity) was 3,855,987,133.58 RMB[59] - Total liabilities and owner's equity (or shareholders' equity) amounted to 5,726,208,804.59 RMB[59] Accounting Standards and Reporting - The company implemented the new revenue standard starting from January 1, 2020, and reported prepayments under contract liabilities[59] - The company did not apply the new revenue standard and new lease standard retrospectively to adjust prior period comparative data[60] - The company did not provide an audit report for this period[60]